"Marina A. Dobrovolskaia" appeared in Books and Chapters

entries per page

Filter:

Showing 0 to 0 of 0 entries

Book	Author(s)	Year	Publisher
No data available in table
Boook	Author(s)	Year	Publisher

Showing 0 to 0 of 0 entries

entries per page

Filter:

Showing 1 to 20 of 36 entries

Chapter	Author(s)	Book	Book Authors	Year	Publisher
Understanding Nanoparticle Immunotoxicity to Develop Safe Medical Devices	Marina A. Dobrovolskaia	The Immune Response to Implanted Materials and Devices: The Impact of the Immune System on the Success of an Implant	Bruna Corradetti	1st ed. 2017	Springer International Publishing
Nanoparticle Toxicity: General Overview and Insights Into Immunological Compatibility	Marina A. Dobrovolskaia	Pharmaceutical Nanotechnology - Innovation and Production	Jean Cornier Dr.,	2017	John Wiley & Sons
Gold Nanoparticle Quantitation via Fluorescence in Solution and Cell Culture	Parag Aggarwal; Marina A. Dobrovolskaia	Characterization of Nanoparticles Intended for Drug Delivery	Scott E. McNeil	2011	Humana Press
Use of Human Peripheral Blood Mononuclear Cells to Define Immunological Properties of Nucleic Acid Nanoparticles*	Marina A. Dobrovolskaia; Kirill A. Afonin	Therapeutic RNA Nanotechnology: Immunomodulation and Dynamicity	Kirill A. Afonin; Morgan Chandler	2021	Routledge
Defining Immunological Properties of Nucleic Acid Nanoparticles Using Human Peripheral Blood Mononuclear Cells	Marina A. Dobrovolskaia; Kirill A. Afonin	RNA Nanotechnology and Therapeutics	Peixuan Guo; Kirill A. Afonin	2022	Routledge
Interaction Between Nanoparticles and Plasma Proteins: Effects on Nanoparticle Biodistribution and Toxicity	Anna N. Ilinskaya; Marina A. Dobrovolskaia	Polymer Nanoparticles for Nanomedicines: A Guide for their Design, Preparation and Development	Christine Vauthier; Gilles Ponchel	1st ed. 2016	Springer International Publishing
Detection and Quantitative Evaluation of Endotoxin Contamination in Nanoparticle Formulations by LAL-Based Assays	Barry W. Neun; Marina A. Dobrovolskaia	Characterization of Nanoparticles Intended for Drug Delivery	Scott E. McNeil	2011	Humana Press
Analysis of Microbial Contamination in Nanoparticle Formulations	Timothy M. Potter; Marina A. Dobrovolskaia	Characterization of Nanoparticles Intended for Drug Delivery	Scott E. McNeil	2011	Humana Press
Method for Analysis of Nanoparticle Hemolytic Properties In Vitro	Barry W. Neun; Marina A. Dobrovolskaia	Characterization of Nanoparticles Intended for Drug Delivery	Scott E. McNeil	2011	Humana Press
Method for In Vitro Analysis of Nanoparticle Thrombogenic Properties	Barry W. Neun; Marina A. Dobrovolskaia	Characterization of Nanoparticles Intended for Drug Delivery	Scott E. McNeil	2011	Humana Press
Qualitative Analysis of Total Complement Activation by Nanoparticles	Barry W. Neun; Marina A. Dobrovolskaia	Characterization of Nanoparticles Intended for Drug Delivery	Scott E. McNeil	2011	Humana Press
Understanding Endotoxin and β-Glucan Contamination in Nanotechnology-Based Drug Products	Barry W. Neun; Marina A. Dobrovolskaia	Endotoxin Detection and Control in Pharma, Limulus, and Mammalian Systems	Kevin L. Williams	1st ed. 2019	Springer International Publishing
Considerations and Some Practical Solutions to Overcome Nanoparticle Interference with LAL Assays and to Avoid Endotoxin Contamination in Nanoformulations	Barry W. Neun; Marina A. Dobrovolskaia	Characterization of Nanoparticles Intended for Drug Delivery	Scott E. McNeil	2nd ed. 2018	Springer New York
Analysis of Nanoparticle-Adjuvant Properties In Vivo	Barry W. Neun; Marina A. Dobrovolskaia	Characterization of Nanoparticles Intended for Drug Delivery	Scott E. McNeil	2nd ed. 2018	Springer New York
Immunological properties of engineered nanomaterials	Marina A. Dobrovolskaia; Scott E. McNeil	Nanoscience and technology: a collection of reviews from Nature journals	Peter Rodgers	2009	World Scientific;Nature Pub. Group
Viral Noncoding RNAs in Modulating Cellular Defense and Their Potential for RNA Nanotechnology	Martin Panigaj; Marina A. Dobrovolskaia; Kirill A. Afonin	RNA Nanotechnology and Therapeutics	Peixuan Guo; Kirill A. Afonin	2022	Routledge
Current Understanding of Interactions between Nanoparticles and the Immune System	Marina A. Dobrovolskaia; Michael Shurin; Anna A. Shvedova	Immune Aspects of Biopharmaceuticals and Nanomedicines	Raj Bawa; Janos Szebeni; Thomas Webster; Gerald F. Audette	2018	Routledge
Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nanotechnology*	Kirill A. Afonin; Marina A. Dobrovolskaia; George Church; Mark Bathe	Therapeutic RNA Nanotechnology: Immunomodulation and Dynamicity	Kirill A. Afonin; Morgan Chandler	2021	Routledge
Method for Analysis of Nanoparticle Effects on Cellular Chemotaxis	Sarah L. Skoczen; Timothy M. Potter; Marina A. Dobrovolskaia	Characterization of Nanoparticles Intended for Drug Delivery	Scott E. McNeil	2011	Humana Press
In Vitro Analysis of Nanoparticle Uptake by Macrophages Using Chemiluminescence	Sarah L. Skoczen; Timothy M. Potter; Marina A. Dobrovolskaia	Characterization of Nanoparticles Intended for Drug Delivery	Scott E. McNeil	2011	Humana Press
Chapter	Author(s)	Book	Book Authors	Year	Publisher

Showing 1 to 20 of 36 entries